This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Hemocorm Limited. Active years: 2006-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Middlesex, GB (2006 - 2012)
- Genoa, IT (2013)
Company Filing History:
Years Active: 2006-2013
Title: An Overview of Inventor Roberto Angelo Motterlini
Introduction
Roberto Angelo Motterlini is an esteemed inventor located in Middlesex, GB, known for his significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, he has been at the forefront of innovative therapeutic solutions that employ complex chemical compositions for the benefit of human health.
Latest Patents
Roberto's latest patents center around the therapeutic delivery of carbon monoxide. His first patent details compounds, pharmaceutical compositions, and methods for the delivery of carbon monoxide to humans and other mammals. This innovation employs transition metal complexes that feature at least a substituted cyclopentadienyl, indenyl, or fluorenyl ligand, along with two or more carbonyl ligands. The second patent highlights how metal carbonyls are utilized to deliver carbon monoxide, exhibiting biological activity, such as inducing vasodilatation and inhibiting transplant rejection. Notably, the carbonyl metals are typically sourced from groups 7 to 10, including Iron (Fe) and Ruthenium (Ru). Additionally, these carbonyls may contain ligands other than CO, like amine acids, which help to modulate CO release properties and enhance solubility.
Career Highlights
Roberto Angelo Motterlini works at Hemocorm Limited, where he has engaged in pioneering research aimed at improving medical treatment options through innovative chemical approaches. His extensive work has made substantial contributions to the understanding and practical applications of carbon monoxide in medical therapies.
Collaborations
Throughout his career, Roberto has collaborated with notable colleagues such as Brian Ernest Mann and Tony Richard Johnson. These partnerships have helped advance his research and expand the impact of his innovative work in the pharmaceutical field.
Conclusion
Roberto Angelo Motterlini continues to be an influential figure in the realm of therapeutic innovations, particularly those involving carbon monoxide delivery mechanisms. His patents reflect a commitment to advancing medical knowledge and improving treatment options, making him a notable inventor in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile